Evidence map›Paper›PMID 20842532›Full record

ReviewQuality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation2010

Biological pathways and genetic variables involved in pain.

Qiuling Shi, Charles S Cleeland, Pål Klepstad, Christine Miaskowski, Nancy L Pedersen, GeneQOL Consortium

Erratum issuedAbstract readReview
PubMed Publisher
In one paragraph

Review in Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 37 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. The impact of UGT2B7 C802T and CYP3A4*1G polymorphisms on pain relief in cancer patients receiving oxycontin.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2018
    Article
  7. Article
  8. Article
  9. Genetic variations underlying self-reported physical functioning: a review.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2015
    Review
  10. Article
  11. Biological pathways, candidate genes, and molecular markers associated with quality-of-life domains: an update.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2014
    Review
  12. Biological pathways and genetic mechanisms involved in social functioning.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2013
    Article
  13. Review
  14. Review
  15. Review
  16. Genetic variations and patient-reported quality of life among patients with lung cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2012
    Article
  17. Review
  18. Analgesic-like activity of essential oils constituents.Molecules (Basel, Switzerland) · 2011
    Review
  19. Article
4 · The record

Corrections and comments

  • Erratum issued
    GeneQOL Consortium [added]; multiple investigator names added
5 · Who and what money

Authors and funding

6 authors at 4 institutions in 4 countries.

Qiuling ShiDepartment of Symptom Research, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1450, Houston, TX 77030, USA. qshi@mdanderson.org
Charles S Cleeland
Pål Klepstad
Christine Miaskowski
Nancy L Pedersen
GeneQOL Consortium
The University of Texas MD Anderson Cancer Center · USKarolinska Institutet · SESt Olav's University Hospital · NOUniversidad Católica de Santa Fe · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis paper summarizes current knowledge of pain-related and analgesic-related pathways as well as genetic variations involved in pain perception and management.

methodsThe pain group of the GENEQOL Consortium was given the task of summarizing the current status of research on genetic variations in pain and analgesic efficacy. This review is neither exhaustive nor comprehensive; we focus primarily on single-nucleotide polymorphisms.

resultsTwo categories of potential genetic pain-perception pathways were identified: neurotransmission modulators and mechanisms that affect inflammation. Four categories were identified for analgesic efficacy: genes related to receptor interaction, modulation of opioid effects, metabolism, and transport. Various genetic variations involved in these pathways are proposed as candidate genetic markers for pain perception and for individual sensitivity to analgesics.

conclusionsCandidate gene association studies have been used to provide evidence for the genetic modulation of pain perception and response to analgesics. However, the nature and range of genetic modulation of pain is not well addressed due to the limited number of patients and the limited number of genes and genetic variants investigated in studies to date. Moreover, personalized analgesic treatments will require a more complete understanding of the effects of genetic variants and gene-gene interactions in response to analgesics.

Indexed as

Polymorphism, Single NucleotideAnalgesicsATP Binding Cassette Transporter, Subfamily B, Member 1Cytochrome P-450 Enzyme SystemHumansInflammationPainPain PerceptionSynaptic TransmissionAnalgesicsATP Binding Cassette Transporter, Subfamily B, Member 1Cytochrome P-450 Enzyme System

Identifiers

PMID20842532
OpenAlexW1998613059

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.